Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

NCT07078591 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Azacitidine (AZA)
DRUG: Daunorubicin
DRUG: Idarubicin（IDA）
DRUG: Cytarabine (Ara-C)
BIOLOGICAL: GPBMC infusion

Sponsor

Beijing 302 Hospital